BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 498718)

  • 1. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nonlinear disposition kinetics of sulfamethazine.
    du Souich P; Lalka D; Slaughter R; Elvin AT; McLean AJ
    Clin Pharmacol Ther; 1979 Feb; 25(2):172-83. PubMed ID: 759070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation polymorphism and leprosy.
    Eze LC; Okpogba AN; Ogan AU
    Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfamethazine absorption and disposition: effect of surgical procedures for gastroduodenal ulcers.
    Calvo R; Sarabia S; Carlos R; Du Souich P
    Biopharm Drug Dispos; 1987; 8(2):115-24. PubMed ID: 3593892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonazepam acetylation in fast and slow acetylators.
    Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of smoking on sulfamethazine acetylation.
    Miller ME; Cosgriff JM
    Drug Intell Clin Pharm; 1984; 18(7-8):620-2. PubMed ID: 6745090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation of sulfamethazine in a Nigerian population.
    Eze LC; Obidoa O
    Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
    Reeves PT; Minchin RF; Ilett KF
    Drug Metab Dispos; 1988; 16(1):110-5. PubMed ID: 2894938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of acetylating capacity with complete Freund's adjuvant and hydrocortisone in the rabbit.
    du Souich P; Courteau H
    Drug Metab Dispos; 1981; 9(3):279-83. PubMed ID: 6113941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.
    Lee EJ; Lee LK
    Br J Clin Pharmacol; 1982 Mar; 13(3):375-8. PubMed ID: 7059437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylation of the heterocyclic amine batracylin by human liver.
    Stevens GJ; Payton M; Sim E; McQueen CA
    Drug Metab Dispos; 1999 Sep; 27(9):966-71. PubMed ID: 10460792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.